Polymyositis and dermatomyositis in Sarawak: a profile of patients treated in the Sarawak general hospital
Identifieur interne : 000813 ( Istex/Corpus ); précédent : 000812; suivant : 000814Polymyositis and dermatomyositis in Sarawak: a profile of patients treated in the Sarawak general hospital
Auteurs : C. L. Teh ; J. S. Wong ; H. H. SooSource :
- Rheumatology International [ 0172-8172 ] ; 2012-01-01.
English descriptors
- KwdEn :
Abstract
Abstract: We performed a cross-sectional study of the demography, clinical and laboratory features of patients with polymyositis and dermatomyositis followed up in our centre from 2006 to 2009. There were 12 cases, with the majority of them (58.3%) being woman. They have a mean age of 57.8 years and mean disease duration of 11.83 (SD 9.92) months. Our patients comprised of multi-ethnic groups with predominantly Chinese (83.3%), Sarawak natives (8.3%) and Malays (8.3%). They have a mean lag time to diagnosis of 3.67 (SD 4.27) months. Nine (75%) patients had dermatomyositis and 3(25%) had polymyositis. The common clinical manifestations found in our patients were proximal myopathy (100%), neck weakness (33.3%), dysphagia (33.3%) and interstitial lung disease (33.3%). For the nine patients with dermatomyositis, the most common dermatological manifestations were shawl sign (88.9%) and V sign (88.9%). Muscle enzymes were raised in 91.7% of patients. Electromyographies were carried out in four patients, and only one of our patients had muscle biopsy. Only 41.7% of our patients have positive ANA. The majority received prednisolone (100%) and hydroxychloroquine (58.3%). Malignancy occurred in five (three nasopharyngeal carcinomas, one sigmoid colon cancer and one lung cancer) out of the nine dermatomyositis patients but none in the polymyositis group. The mortality rate in our group was 4(33.3%) over the 4-year period. This study demonstrated the rarity of PM/DM in our centre with considerable lag time to diagnosis in our patients. Despite lack of muscle biopsy in our centre, our centre achieved appropriate diagnosis and management of PM/DM.
Url:
DOI: 10.1007/s00296-010-1745-2
Links to Exploration step
ISTEX:6AAFE2B2AA57AC64EAB58D0070DC4BC6DC2CE739Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Polymyositis and dermatomyositis in Sarawak: a profile of patients treated in the Sarawak general hospital</title><author><name sortKey="Teh, C L" sort="Teh, C L" uniqKey="Teh C" first="C. L." last="Teh">C. L. Teh</name><affiliation><mods:affiliation>Unit of Rheumatology, Department of Medicine, Sarawak General Hospital, Jalan Hospital, 93450, Kuching, Sarawak, East Malaysia</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: tehchenglay@yahoo.com</mods:affiliation></affiliation></author><author><name sortKey="Wong, J S" sort="Wong, J S" uniqKey="Wong J" first="J. S." last="Wong">J. S. Wong</name><affiliation><mods:affiliation>Unit of Rheumatology, Department of Medicine, Sarawak General Hospital, Jalan Hospital, 93450, Kuching, Sarawak, East Malaysia</mods:affiliation></affiliation></author><author><name sortKey="Soo, H H" sort="Soo, H H" uniqKey="Soo H" first="H. H." last="Soo">H. H. Soo</name><affiliation><mods:affiliation>Soo’s Neurology Clinic, Sarawak, Malaysia</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:6AAFE2B2AA57AC64EAB58D0070DC4BC6DC2CE739</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1007/s00296-010-1745-2</idno><idno type="url">https://api.istex.fr/ark:/67375/VQC-NHMDB8ZP-J/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000813</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000813</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Polymyositis and dermatomyositis in Sarawak: a profile of patients treated in the Sarawak general hospital</title><author><name sortKey="Teh, C L" sort="Teh, C L" uniqKey="Teh C" first="C. L." last="Teh">C. L. Teh</name><affiliation><mods:affiliation>Unit of Rheumatology, Department of Medicine, Sarawak General Hospital, Jalan Hospital, 93450, Kuching, Sarawak, East Malaysia</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: tehchenglay@yahoo.com</mods:affiliation></affiliation></author><author><name sortKey="Wong, J S" sort="Wong, J S" uniqKey="Wong J" first="J. S." last="Wong">J. S. Wong</name><affiliation><mods:affiliation>Unit of Rheumatology, Department of Medicine, Sarawak General Hospital, Jalan Hospital, 93450, Kuching, Sarawak, East Malaysia</mods:affiliation></affiliation></author><author><name sortKey="Soo, H H" sort="Soo, H H" uniqKey="Soo H" first="H. H." last="Soo">H. H. Soo</name><affiliation><mods:affiliation>Soo’s Neurology Clinic, Sarawak, Malaysia</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Rheumatology International</title><title level="j" type="sub">Clinical and Experimental Investigations</title><title level="j" type="abbrev">Rheumatol Int</title><idno type="ISSN">0172-8172</idno><idno type="eISSN">1437-160X</idno><imprint><publisher>Springer-Verlag</publisher><pubPlace>Berlin/Heidelberg</pubPlace><date type="published" when="2012-01-01">2012-01-01</date><biblScope unit="volume">32</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="265">265</biblScope><biblScope unit="page" to="268">268</biblScope></imprint><idno type="ISSN">0172-8172</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0172-8172</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Dermatomyositis</term><term>Malignancy</term><term>Polymyositis</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: We performed a cross-sectional study of the demography, clinical and laboratory features of patients with polymyositis and dermatomyositis followed up in our centre from 2006 to 2009. There were 12 cases, with the majority of them (58.3%) being woman. They have a mean age of 57.8 years and mean disease duration of 11.83 (SD 9.92) months. Our patients comprised of multi-ethnic groups with predominantly Chinese (83.3%), Sarawak natives (8.3%) and Malays (8.3%). They have a mean lag time to diagnosis of 3.67 (SD 4.27) months. Nine (75%) patients had dermatomyositis and 3(25%) had polymyositis. The common clinical manifestations found in our patients were proximal myopathy (100%), neck weakness (33.3%), dysphagia (33.3%) and interstitial lung disease (33.3%). For the nine patients with dermatomyositis, the most common dermatological manifestations were shawl sign (88.9%) and V sign (88.9%). Muscle enzymes were raised in 91.7% of patients. Electromyographies were carried out in four patients, and only one of our patients had muscle biopsy. Only 41.7% of our patients have positive ANA. The majority received prednisolone (100%) and hydroxychloroquine (58.3%). Malignancy occurred in five (three nasopharyngeal carcinomas, one sigmoid colon cancer and one lung cancer) out of the nine dermatomyositis patients but none in the polymyositis group. The mortality rate in our group was 4(33.3%) over the 4-year period. This study demonstrated the rarity of PM/DM in our centre with considerable lag time to diagnosis in our patients. Despite lack of muscle biopsy in our centre, our centre achieved appropriate diagnosis and management of PM/DM.</div></front></TEI><istex><corpusName>springer-journals</corpusName><author><json:item><name>C. L. Teh</name><affiliations><json:string>Unit of Rheumatology, Department of Medicine, Sarawak General Hospital, Jalan Hospital, 93450, Kuching, Sarawak, East Malaysia</json:string><json:string>E-mail: tehchenglay@yahoo.com</json:string></affiliations></json:item><json:item><name>J. S. Wong</name><affiliations><json:string>Unit of Rheumatology, Department of Medicine, Sarawak General Hospital, Jalan Hospital, 93450, Kuching, Sarawak, East Malaysia</json:string></affiliations></json:item><json:item><name>H. H. Soo</name><affiliations><json:string>Soo’s Neurology Clinic, Sarawak, Malaysia</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Polymyositis</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Dermatomyositis</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Malignancy</value></json:item></subject><articleId><json:string>1745</json:string><json:string>s00296-010-1745-2</json:string></articleId><arkIstex>ark:/67375/VQC-NHMDB8ZP-J</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>BriefCommunication</json:string></originalGenre><abstract>Abstract: We performed a cross-sectional study of the demography, clinical and laboratory features of patients with polymyositis and dermatomyositis followed up in our centre from 2006 to 2009. There were 12 cases, with the majority of them (58.3%) being woman. They have a mean age of 57.8 years and mean disease duration of 11.83 (SD 9.92) months. Our patients comprised of multi-ethnic groups with predominantly Chinese (83.3%), Sarawak natives (8.3%) and Malays (8.3%). They have a mean lag time to diagnosis of 3.67 (SD 4.27) months. Nine (75%) patients had dermatomyositis and 3(25%) had polymyositis. The common clinical manifestations found in our patients were proximal myopathy (100%), neck weakness (33.3%), dysphagia (33.3%) and interstitial lung disease (33.3%). For the nine patients with dermatomyositis, the most common dermatological manifestations were shawl sign (88.9%) and V sign (88.9%). Muscle enzymes were raised in 91.7% of patients. Electromyographies were carried out in four patients, and only one of our patients had muscle biopsy. Only 41.7% of our patients have positive ANA. The majority received prednisolone (100%) and hydroxychloroquine (58.3%). Malignancy occurred in five (three nasopharyngeal carcinomas, one sigmoid colon cancer and one lung cancer) out of the nine dermatomyositis patients but none in the polymyositis group. The mortality rate in our group was 4(33.3%) over the 4-year period. This study demonstrated the rarity of PM/DM in our centre with considerable lag time to diagnosis in our patients. Despite lack of muscle biopsy in our centre, our centre achieved appropriate diagnosis and management of PM/DM.</abstract><qualityIndicators><score>7.009</score><pdfWordCount>2009</pdfWordCount><pdfCharCount>13267</pdfCharCount><pdfVersion>1.4</pdfVersion><pdfPageCount>4</pdfPageCount><pdfPageSize>595.276 x 790.866 pts</pdfPageSize><refBibsNative>false</refBibsNative><abstractWordCount>250</abstractWordCount><abstractCharCount>1661</abstractCharCount><keywordCount>3</keywordCount></qualityIndicators><title>Polymyositis and dermatomyositis in Sarawak: a profile of patients treated in the Sarawak general hospital</title><genre><json:string>brief-communication</json:string></genre><host><title>Rheumatology International</title><language><json:string>unknown</json:string></language><publicationDate>2012</publicationDate><copyrightDate>2012</copyrightDate><issn><json:string>0172-8172</json:string></issn><eissn><json:string>1437-160X</json:string></eissn><journalId><json:string>296</json:string></journalId><volume>32</volume><issue>1</issue><pages><first>265</first><last>268</last></pages><genre><json:string>journal</json:string></genre><subject><json:item><value>Rheumatology</value></json:item></subject></host><ark><json:string>ark:/67375/VQC-NHMDB8ZP-J</json:string></ark><publicationDate>2012</publicationDate><copyrightDate>2011</copyrightDate><doi><json:string>10.1007/s00296-010-1745-2</json:string></doi><id>6AAFE2B2AA57AC64EAB58D0070DC4BC6DC2CE739</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/VQC-NHMDB8ZP-J/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/VQC-NHMDB8ZP-J/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/VQC-NHMDB8ZP-J/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Polymyositis and dermatomyositis in Sarawak: a profile of patients treated in the Sarawak general hospital</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher scheme="https://scientific-publisher.data.istex.fr">Springer-Verlag</publisher><pubPlace>Berlin/Heidelberg</pubPlace><availability><licence><p>Springer-Verlag, 2011</p></licence><p scheme="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-3XSW68JL-F">springer</p></availability><date>2010-08-11</date></publicationStmt><notesStmt><note type="brief-communication" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-S9SX2MFS-0">brief-communication</note><note type="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note><note>Short Communication</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Polymyositis and dermatomyositis in Sarawak: a profile of patients treated in the Sarawak general hospital</title><author xml:id="author-0000" corresp="yes"><persName><forename type="first">C.</forename><surname>Teh</surname></persName><email>tehchenglay@yahoo.com</email><affiliation>Unit of Rheumatology, Department of Medicine, Sarawak General Hospital, Jalan Hospital, 93450, Kuching, Sarawak, East Malaysia</affiliation></author><author xml:id="author-0001"><persName><forename type="first">J.</forename><surname>Wong</surname></persName><affiliation>Unit of Rheumatology, Department of Medicine, Sarawak General Hospital, Jalan Hospital, 93450, Kuching, Sarawak, East Malaysia</affiliation></author><author xml:id="author-0002"><persName><forename type="first">H.</forename><surname>Soo</surname></persName><affiliation>Soo’s Neurology Clinic, Sarawak, Malaysia</affiliation></author><idno type="istex">6AAFE2B2AA57AC64EAB58D0070DC4BC6DC2CE739</idno><idno type="ark">ark:/67375/VQC-NHMDB8ZP-J</idno><idno type="DOI">10.1007/s00296-010-1745-2</idno><idno type="article-id">1745</idno><idno type="article-id">s00296-010-1745-2</idno></analytic><monogr><title level="j">Rheumatology International</title><title level="j" type="sub">Clinical and Experimental Investigations</title><title level="j" type="abbrev">Rheumatol Int</title><idno type="pISSN">0172-8172</idno><idno type="eISSN">1437-160X</idno><idno type="journal-ID">true</idno><idno type="issue-article-count">50</idno><idno type="volume-issue-count">12</idno><imprint><publisher>Springer-Verlag</publisher><pubPlace>Berlin/Heidelberg</pubPlace><date type="published" when="2012-01-01"></date><biblScope unit="volume">32</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="265">265</biblScope><biblScope unit="page" to="268">268</biblScope></imprint></monogr></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2010-08-11</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Abstract: We performed a cross-sectional study of the demography, clinical and laboratory features of patients with polymyositis and dermatomyositis followed up in our centre from 2006 to 2009. There were 12 cases, with the majority of them (58.3%) being woman. They have a mean age of 57.8 years and mean disease duration of 11.83 (SD 9.92) months. Our patients comprised of multi-ethnic groups with predominantly Chinese (83.3%), Sarawak natives (8.3%) and Malays (8.3%). They have a mean lag time to diagnosis of 3.67 (SD 4.27) months. Nine (75%) patients had dermatomyositis and 3(25%) had polymyositis. The common clinical manifestations found in our patients were proximal myopathy (100%), neck weakness (33.3%), dysphagia (33.3%) and interstitial lung disease (33.3%). For the nine patients with dermatomyositis, the most common dermatological manifestations were shawl sign (88.9%) and V sign (88.9%). Muscle enzymes were raised in 91.7% of patients. Electromyographies were carried out in four patients, and only one of our patients had muscle biopsy. Only 41.7% of our patients have positive ANA. The majority received prednisolone (100%) and hydroxychloroquine (58.3%). Malignancy occurred in five (three nasopharyngeal carcinomas, one sigmoid colon cancer and one lung cancer) out of the nine dermatomyositis patients but none in the polymyositis group. The mortality rate in our group was 4(33.3%) over the 4-year period. This study demonstrated the rarity of PM/DM in our centre with considerable lag time to diagnosis in our patients. Despite lack of muscle biopsy in our centre, our centre achieved appropriate diagnosis and management of PM/DM.</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>Polymyositis</term></item><item><term>Dermatomyositis</term></item><item><term>Malignancy</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>Medicine & Public Health</head><item><term>Rheumatology</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2010-08-11">Created</change><change when="2012-01-01">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/VQC-NHMDB8ZP-J/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="corpus springer-journals not found" wicri:toSee="no header"><istex:xmlDeclaration>version="1.0" encoding="UTF-8"</istex:xmlDeclaration><istex:docType PUBLIC="-//Springer-Verlag//DTD A++ V2.4//EN" URI="http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd" name="istex:docType"></istex:docType><istex:document><Publisher><PublisherInfo><PublisherName>Springer-Verlag</PublisherName><PublisherLocation>Berlin/Heidelberg</PublisherLocation></PublisherInfo><Journal OutputMedium="All"><JournalInfo JournalProductType="NonStandardArchiveJournal" NumberingStyle="Unnumbered"><JournalID>296</JournalID><JournalPrintISSN>0172-8172</JournalPrintISSN><JournalElectronicISSN>1437-160X</JournalElectronicISSN><JournalTitle>Rheumatology International</JournalTitle><JournalSubTitle>Clinical and Experimental Investigations</JournalSubTitle><JournalAbbreviatedTitle>Rheumatol Int</JournalAbbreviatedTitle><JournalSubjectGroup><JournalSubject Type="Primary">Medicine & Public Health</JournalSubject><JournalSubject Type="Secondary">Rheumatology</JournalSubject></JournalSubjectGroup></JournalInfo><Volume OutputMedium="All"><VolumeInfo TocLevels="0" VolumeType="Regular"><VolumeIDStart>32</VolumeIDStart><VolumeIDEnd>32</VolumeIDEnd><VolumeIssueCount>12</VolumeIssueCount></VolumeInfo><Issue IssueType="Regular" OutputMedium="All"><IssueInfo IssueType="Regular" TocLevels="0"><IssueIDStart>1</IssueIDStart><IssueIDEnd>1</IssueIDEnd><IssueArticleCount>50</IssueArticleCount><IssueHistory><OnlineDate><Year>2012</Year><Month>1</Month><Day>6</Day></OnlineDate><PrintDate><Year>2012</Year><Month>1</Month><Day>5</Day></PrintDate><CoverDate><Year>2012</Year><Month>1</Month></CoverDate><PricelistYear>2012</PricelistYear></IssueHistory><IssueCopyright><CopyrightHolderName>Springer-Verlag</CopyrightHolderName><CopyrightYear>2012</CopyrightYear></IssueCopyright></IssueInfo><Article ID="s00296-010-1745-2" OutputMedium="All"><ArticleInfo ArticleType="BriefCommunication" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0"><ArticleID>1745</ArticleID><ArticleDOI>10.1007/s00296-010-1745-2</ArticleDOI><ArticleSequenceNumber>44</ArticleSequenceNumber><ArticleTitle Language="En" OutputMedium="All">Polymyositis and dermatomyositis in Sarawak: a profile of patients treated in the Sarawak general hospital</ArticleTitle><ArticleCategory>Short Communication</ArticleCategory><ArticleFirstPage>265</ArticleFirstPage><ArticleLastPage>268</ArticleLastPage><ArticleHistory><RegistrationDate><Year>2010</Year><Month>12</Month><Day>30</Day></RegistrationDate><Received><Year>2010</Year><Month>8</Month><Day>11</Day></Received><Accepted><Year>2010</Year><Month>12</Month><Day>30</Day></Accepted><OnlineDate><Year>2011</Year><Month>1</Month><Day>18</Day></OnlineDate></ArticleHistory><ArticleCopyright><CopyrightHolderName>Springer-Verlag</CopyrightHolderName><CopyrightYear>2011</CopyrightYear></ArticleCopyright><ArticleGrants Type="Regular"><MetadataGrant Grant="OpenAccess"></MetadataGrant><AbstractGrant Grant="OpenAccess"></AbstractGrant><BodyPDFGrant Grant="Restricted"></BodyPDFGrant><BodyHTMLGrant Grant="Restricted"></BodyHTMLGrant><BibliographyGrant Grant="Restricted"></BibliographyGrant><ESMGrant Grant="Restricted"></ESMGrant></ArticleGrants></ArticleInfo><ArticleHeader><AuthorGroup><Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1"><AuthorName DisplayOrder="Western"><GivenName>C.</GivenName><GivenName>L.</GivenName><FamilyName>Teh</FamilyName></AuthorName><Contact><Email>tehchenglay@yahoo.com</Email></Contact></Author><Author AffiliationIDS="Aff1"><AuthorName DisplayOrder="Western"><GivenName>J.</GivenName><GivenName>S.</GivenName><FamilyName>Wong</FamilyName></AuthorName></Author><Author AffiliationIDS="Aff2"><AuthorName DisplayOrder="Western"><GivenName>H.</GivenName><GivenName>H.</GivenName><FamilyName>Soo</FamilyName></AuthorName></Author><Affiliation ID="Aff1"><OrgDivision>Unit of Rheumatology, Department of Medicine</OrgDivision><OrgName>Sarawak General Hospital, Jalan Hospital</OrgName><OrgAddress><Postcode>93450</Postcode><City>Kuching</City><State>Sarawak</State><Country Code="MY">East Malaysia</Country></OrgAddress></Affiliation><Affiliation ID="Aff2"><OrgName>Soo’s Neurology Clinic</OrgName><OrgAddress><City>Sarawak</City><Country Code="MY">Malaysia</Country></OrgAddress></Affiliation></AuthorGroup><Abstract ID="Abs1" Language="En" OutputMedium="All"><Heading>Abstract</Heading><Para>We performed a cross-sectional study of the demography, clinical and laboratory features of patients with polymyositis and dermatomyositis followed up in our centre from 2006 to 2009. There were 12 cases, with the majority of them (58.3%) being woman. They have a mean age of 57.8 years and mean disease duration of 11.83 (SD 9.92) months. Our patients comprised of multi-ethnic groups with predominantly Chinese (83.3%), Sarawak natives (8.3%) and Malays (8.3%). They have a mean lag time to diagnosis of 3.67 (SD 4.27) months. Nine (75%) patients had dermatomyositis and 3(25%) had polymyositis. The common clinical manifestations found in our patients were proximal myopathy (100%), neck weakness (33.3%), dysphagia (33.3%) and interstitial lung disease (33.3%). For the nine patients with dermatomyositis, the most common dermatological manifestations were shawl sign (88.9%) and V sign (88.9%). Muscle enzymes were raised in 91.7% of patients. Electromyographies were carried out in four patients, and only one of our patients had muscle biopsy. Only 41.7% of our patients have positive ANA. The majority received prednisolone (100%) and hydroxychloroquine (58.3%). Malignancy occurred in five (three nasopharyngeal carcinomas, one sigmoid colon cancer and one lung cancer) out of the nine dermatomyositis patients but none in the polymyositis group. The mortality rate in our group was 4(33.3%) over the 4-year period. This study demonstrated the rarity of PM/DM in our centre with considerable lag time to diagnosis in our patients. Despite lack of muscle biopsy in our centre, our centre achieved appropriate diagnosis and management of PM/DM.</Para></Abstract><KeywordGroup Language="En" OutputMedium="All"><Heading>Keywords</Heading><Keyword>Polymyositis</Keyword><Keyword>Dermatomyositis</Keyword><Keyword>Malignancy</Keyword></KeywordGroup></ArticleHeader><NoBody></NoBody></Article></Issue></Volume></Journal></Publisher></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Polymyositis and dermatomyositis in Sarawak: a profile of patients treated in the Sarawak general hospital</title></titleInfo><titleInfo type="alternative" contentType="CDATA"><title>Polymyositis and dermatomyositis in Sarawak: a profile of patients treated in the Sarawak general hospital</title></titleInfo><name type="personal" displayLabel="corresp"><namePart type="given">C.</namePart><namePart type="given">L.</namePart><namePart type="family">Teh</namePart><affiliation>Unit of Rheumatology, Department of Medicine, Sarawak General Hospital, Jalan Hospital, 93450, Kuching, Sarawak, East Malaysia</affiliation><affiliation>E-mail: tehchenglay@yahoo.com</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="given">S.</namePart><namePart type="family">Wong</namePart><affiliation>Unit of Rheumatology, Department of Medicine, Sarawak General Hospital, Jalan Hospital, 93450, Kuching, Sarawak, East Malaysia</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H.</namePart><namePart type="given">H.</namePart><namePart type="family">Soo</namePart><affiliation>Soo’s Neurology Clinic, Sarawak, Malaysia</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="brief-communication" displayLabel="BriefCommunication" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-S9SX2MFS-0">brief-communication</genre><originInfo><publisher>Springer-Verlag</publisher><place><placeTerm type="text">Berlin/Heidelberg</placeTerm></place><dateCreated encoding="w3cdtf">2010-08-11</dateCreated><dateIssued encoding="w3cdtf">2012-01-01</dateIssued><copyrightDate encoding="w3cdtf">2011</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><abstract lang="en">Abstract: We performed a cross-sectional study of the demography, clinical and laboratory features of patients with polymyositis and dermatomyositis followed up in our centre from 2006 to 2009. There were 12 cases, with the majority of them (58.3%) being woman. They have a mean age of 57.8 years and mean disease duration of 11.83 (SD 9.92) months. Our patients comprised of multi-ethnic groups with predominantly Chinese (83.3%), Sarawak natives (8.3%) and Malays (8.3%). They have a mean lag time to diagnosis of 3.67 (SD 4.27) months. Nine (75%) patients had dermatomyositis and 3(25%) had polymyositis. The common clinical manifestations found in our patients were proximal myopathy (100%), neck weakness (33.3%), dysphagia (33.3%) and interstitial lung disease (33.3%). For the nine patients with dermatomyositis, the most common dermatological manifestations were shawl sign (88.9%) and V sign (88.9%). Muscle enzymes were raised in 91.7% of patients. Electromyographies were carried out in four patients, and only one of our patients had muscle biopsy. Only 41.7% of our patients have positive ANA. The majority received prednisolone (100%) and hydroxychloroquine (58.3%). Malignancy occurred in five (three nasopharyngeal carcinomas, one sigmoid colon cancer and one lung cancer) out of the nine dermatomyositis patients but none in the polymyositis group. The mortality rate in our group was 4(33.3%) over the 4-year period. This study demonstrated the rarity of PM/DM in our centre with considerable lag time to diagnosis in our patients. Despite lack of muscle biopsy in our centre, our centre achieved appropriate diagnosis and management of PM/DM.</abstract><note>Short Communication</note><subject lang="en"><genre>Keywords</genre><topic>Polymyositis</topic><topic>Dermatomyositis</topic><topic>Malignancy</topic></subject><relatedItem type="host"><titleInfo><title>Rheumatology International</title><subTitle>Clinical and Experimental Investigations</subTitle></titleInfo><titleInfo type="abbreviated"><title>Rheumatol Int</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><originInfo><publisher>Springer</publisher><dateIssued encoding="w3cdtf">2012-01-06</dateIssued><copyrightDate encoding="w3cdtf">2012</copyrightDate></originInfo><subject><genre>Medicine & Public Health</genre><topic>Rheumatology</topic></subject><identifier type="ISSN">0172-8172</identifier><identifier type="eISSN">1437-160X</identifier><identifier type="JournalID">296</identifier><identifier type="IssueArticleCount">50</identifier><identifier type="VolumeIssueCount">12</identifier><part><date>2012</date><detail type="volume"><number>32</number><caption>vol.</caption></detail><detail type="issue"><number>1</number><caption>no.</caption></detail><extent unit="pages"><start>265</start><end>268</end></extent></part><recordInfo><recordOrigin>Springer-Verlag, 2012</recordOrigin></recordInfo></relatedItem><identifier type="istex">6AAFE2B2AA57AC64EAB58D0070DC4BC6DC2CE739</identifier><identifier type="ark">ark:/67375/VQC-NHMDB8ZP-J</identifier><identifier type="DOI">10.1007/s00296-010-1745-2</identifier><identifier type="ArticleID">1745</identifier><identifier type="ArticleID">s00296-010-1745-2</identifier><accessCondition type="use and reproduction" contentType="copyright">Springer-Verlag, 2011</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-3XSW68JL-F">springer</recordContentSource><recordOrigin>Springer-Verlag, 2011</recordOrigin></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/VQC-NHMDB8ZP-J/record.json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000813 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000813 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:6AAFE2B2AA57AC64EAB58D0070DC4BC6DC2CE739
|texte= Polymyositis and dermatomyositis in Sarawak: a profile of patients treated in the Sarawak general hospital
}}
| This area was generated with Dilib version V0.6.33. |  |